NEWS
Israeli start-up announces funding for
new healthcare data paradigm
H
ealthcare IT startup MDClone has announced that it has
raised US$15 million from OrbiMed Israel Partners, who led
the initial investment in 2016 and Lightspeed Venture Partners,
who led the 2017 financing. MDClone introduces a new approach
to healthcare data access, privacy, analytics and research.
The company addresses one of the greatest challenges and
opportunities in healthcare today: a vast and ever-expanding
amount of data, but a limited ability to derive meaningful insights,
which can lead to more effective patient care and streamlined
hospital operations. MDClone’s Platform dramatically enhances
the utility of data and its Synthetic Data Engine offers the first
solution on the market to eliminate the risk of releasing identifiable
patient information when conducting healthcare analysis and
research. “MDClone has one of the most innovative, experienced
and passionate teams in digital health in Israel, a rare combination
in any startup,” said OrbiMed Managing Director, Anat Naschitz. “I
believe this team can realise the significant potential afforded by
the company’s unique technology, translating it into commercial
success. We see the entire healthcare industry benefiting from
MDClone’s solution.”
“The technology and vision we were presented with caught our
attention and once we spoke to MDClone’s customers throughout
Israel and in the US, we were convinced this is a game-changing
company,” added David Gussarsky, Partner at Lightspeed Venture
Partners. “MDClone offers a giant leap in the way healthcare data is
analysed; with MDClone, organisations are finally capable of realising
the full value of their data assets to transform medical research,
technology development and healthcare delivery.”
MDClone is based in Beersheba, Israel where it was founded in 2016
by CEO Ziv Ofek (Founder and former Chief Innovation Officer of
dbMotion, acquired by Allscripts in 2013), CTO Luz Erez and CFO
Boaz Gur-Lavie. The company released its first product in February
2017 and counts most of Israel’s healthcare system as customers.
//////////////////
Bank Leumi signs €4 million facility for
mobile tech company, Fyber
Beijing, Fyber provides advanced technology
platforms that allow mobile app developers
to monetise their properties by connecting
them with advertisers through technology
and optimisation. Fyber’s expertise are in
mobile video and it reaches over one billion
unique monthly users around the globe.
Shalhevet Mandler, Head of Hi-Tech Finance
at Bank Leumi (UK), commented: “We are
very excited to be able to complete this deal
with Fyber, who is at the cutting edge of the
thriving hi-tech sector – a key area of focus
for Bank Leumi – and we are keen to be able
to contribute to its innovation.”
B
ank Leumi (UK), the multi-specialist
London-based subsidiary of Israel’s
international bank, has completed a €4
million financing deal for German advertising
technology company, Fyber. The facility forms
part of a group-level deal for the tech firm, as
the Bank’s Tel Aviv-based parent approved
16
INTELLIGENTCIO
an US$18 million credit line for Inneractive
Ltd, one of Fyber’s subsidiaries, in 2017. The
group-level deal was led by LeumiTech, the
high-tech banking arm of Leumi.
With six global offices across Berlin, Tel
Aviv, London, New York, San Francisco and
Ziv Elul, CEO at Fyber, said: “Fyber is
committed to empowering mobile app
developers and shaping the future of the
app economy. With this deal, Bank Leumi
is recognising the increasing importance of
the sector. Thanks to this credit line and their
support, we are able to meet our working
capital needs and continue our growth.”
www.intelligentcio.com